Document is current

Article History

Received: 13 July 2025

Accepted: 10 December 2025

First Online: 12 January 2026

Declarations

:

: Ray Manneh has received grants or contracts from AstraZeneca, Amgen, Bayer, BMS, Janssen, MSD, Novartis, Pfizer, Roche. He has also been compensated for his participation in academic events by AstraZeneca, Amgen, Bayer, BMS, Adium, Ipsen, Janssen, Astellas, Eli Lilly, MSD, Merck Serono, Novartis, Pfizer, Roche, GSK. Additionally, R. Manneh received support to attend meetings from MSD, Pfizer, Bayer, AstraZeneca. Francisco Gonzalez is a full-time employee of AstraZeneca and holds stock in the company. Mohamed Elsayed and Pushpalatha Kantharaju are full-time employees of AstraZeneca. Tarek Hashem, Joung Jae Young, Amit Joshi, Sahin Bahadir, Ayman Omar, Salem Eid and Ayman Elsayes have nothing to disclose.

: This non-interventional study used anonymized data with no associated risks to patients. Consequently, the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) at all participating centres (names undisclosed) granted a waiver of informed consent, with the exception of Turkey. For Turkey, the analysis utilized secondary, published data from the national Turkey Prostate Cancer Map registry. The study protocol was approved by the IRB/IEC of all participating centres prior to initiation. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, ICH Good Clinical Practice guidelines, Good Pharmacoepidemiology Practices and all applicable legislation for non-interventional studies. The study was prospectively registered on ClinicalTrials.gov (NCT04801186), and its reporting adheres to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist.